Abbott Laboratories buy BTIG Research
Start price
18.07.25
/
50%
€104.68
Target price
18.07.26
€124.73
Performance (%)
-14.06%
Price
27.01.26
€89.96
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -14.06%. This prediction currently runs until 18.07.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -12.964% | -12.964% |
| iShares Core DAX® | 1.130% | 2.184% |
| iShares Nasdaq 100 | 1.128% | -0.611% |
| iShares Nikkei 225® | 2.610% | 4.958% |
| iShares S&P 500 | -0.006% | -0.952% |
Comments by BTIG_Research for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at BTIG Research from $148.00 to $145.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by BTIG_Research for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€93.02
23.01.26
23.01.26
€119.18
23.01.27
23.01.27
-3.29%
27.01.26
27.01.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€107.90
20.11.25
20.11.25
€125.82
20.11.26
20.11.26
-16.63%
27.01.26
27.01.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€110.96
16.10.25
16.10.25
€124.21
16.10.26
16.10.26
-18.93%
27.01.26
27.01.26